Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $3.86 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-10
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $3.86M, a 16.45% decline from fiscal 2024.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $4.62M, a 33.04% decline from fiscal 2023.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $6.90M, a 31.18% increase from fiscal 2022.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $5.26M, a 23.19% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.86M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $4.62M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $6.90M 10-K · filed 2025-03-13 | |
| 2022-12-31 | $5.26M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $4.27M 10-K · filed 2023-03-16 | |
| 2020-12-31 | $2.51M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $2.13M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $1.44M 10-K · filed 2020-03-31 | $1.44M 10-K · filed 2019-03-14 |
| 2017-12-31 | $810.00K 10-K · filed 2020-03-31 | $805.75K 10-K · filed 2018-03-13 |
| 2016-12-31 | $612.46K 10-K · filed 2019-03-14 | |
| 2015-12-31 | $412.64K 10-K · filed 2018-03-13 | $612.00K 10-K · filed 2016-03-18 |
| 2014-12-31 | $637.00K 10-K · filed 2017-03-10 | $412.64K 10-K · filed 2015-02-27 |
| 2013-12-31 | $637.00K 10-K · filed 2016-03-18 | |
| 2012-12-31 | $164.00K 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |